Navigation Links
TPI Provides Updates on Jiangchuan Macrolide Facility
Date:9/15/2011

fe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please visit: http://www.tianyinpharma.com, or email ir@tianyinpharma.com    

James Jiayuan Tong M.D. Ph.D.
Tel:     +86-28-8551-6696 (Chengdu, China)
          +86-134-3655-0011 (China)

Address:
Tianyin Pharmaceutical
23rd Floor, Unionsun Yangkuo Plaza
No. 2, Block 3, South Renmin Road
Chengdu, 610041
China


'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. VIVUS Provides Regulatory Update on QNEXA
2. Experis Recognizes National Healthcare IT Week, Provides Tips for ICD-10 Assessment Decision
3. Questcor Provides Updated New Paid Prescription Trends
4. ADVENTRX Provides Update on All Three Pipeline Products
5. Cardium Provides Update on Exchange Listing and Related Business Matters
6. MGT Capital Investments, Inc. Provides Update on Recent Developments
7. Verathon® Introduces the Heartscape™ 3D ECG System with 80-Lead Vest in Europe; Technology Provides More Complete Data to Help Diagnose Acute Myocardial Infarction (MI)
8. Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
9. InspireMD Provides Mid-Year Strategic Update
10. Access Pharmaceuticals Provides Second Quarter Update on MuGard Commercial Activities
11. Groupe Athena, Inc. Provides Guidance on Current Orders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015 According ... & Cardiac Rhythm Management Market ECG, Implantable Loop ... Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P ... the global Cardiac Monitoring (CM) and Cardiac Rhythm ... $26,646.5 Million by 2020 from $21,137.7 Million in ...
(Date:7/3/2015)... , July 3, 2015 ... with Broda Technologies Co., Ltd., operating in both the ... the company,s proprietary IntelliGel ® supramolecular hydrogel technology ... development and other ophthalmic therapies. The Broda technology offers ... solution is a free-forming liquid and with low concentrations ...
(Date:7/2/2015)... ResMed Inc. (NYSE: RMD ) today announced ... ended June 30, 2015 results on Thursday, July 30, 2015, ... release with ResMed,s results will be issued after 1:00 p.m. ... to discuss operating results and future outlook. The ... Pacific Time and the live webcast of the call can ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... 2011 Milestone Scientific Inc. (Pink Sheets: ... injection systems for medical and dental markets, today announced ... OTCQB(TM) electronic quotation and trading system under the ticker ... action as a result of the addition of the ...
... Texas, March 14, 2011 (Nasdaq: VRML ... inclusion of OVA1® as part of the recently published ... Obstetrics and Gynecology , the American College of Obstetricians ... published an update committee opinion on the role of ...
Cached Medicine Technology:Milestone Scientific Inc. Commences Trading on the OTC Pink 2OVA1 Included in Latest ACOG/SGO Committee Opinion 2OVA1 Included in Latest ACOG/SGO Committee Opinion 3OVA1 Included in Latest ACOG/SGO Committee Opinion 4
(Date:7/3/2015)... , ... July 03, 2015 , ... Talcum powder attorneys ... replace their existing Talcum Powder Cancer Lawsuit Center website. Just as the previous version ... lawsuit news , offering timely lawsuit updates and ovarian cancer warning information. The site ...
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency ... named Mariah N. Manzanares, MD as the new Medical Director of its Frisco facility. ... director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer ... week that he says will reveal biblical truth and expose popular lies regarding proper ... Bible Say Don’t Have Sex”, immediately goes into the core of the subject by ...
(Date:7/3/2015)... ... ... The Celebrity Dresses is currently running a promotion through July 30th. Anyone who orders ... to get 10% discount on orders that are over $100. , The promotion is ... codes or remember redemption codes. , There is a low price guarantee at ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce ... sweetFrog store located in the Lone Star State. The premium frozen yogurt chain was listed ... store, which opened June 19 in the Village at Bachman Lake, is located at:, 3701 ...
Breaking Medicine News(10 mins):Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2
... of iron oxide could become tools for simultaneous tumor ... toxic effects against brain cancer cells. In mice, researchers ... these particles can deliver antibodies to implanted brain tumors, ... The results are published online by the journal ...
... Gordon HealthDay Reporter , MONDAY, Aug. 2 (HealthDay ... good for the brain, suggests new research. People ... index), meaning those with the greatest blood flow from their ... a healthier brain. In fact, the researchers said that ...
... New Orleans, LA The Louisiana Tumor Registry (LTR) ... of Public Health has been awarded a $12 million ... to continue its work as a SEER (Surveillance, Epidemiology ... competitively awarded SEER cancer registries in the United States., ...
... several challenges to be overcome if therapeutic anticancer vaccines, ... response, are to be successfully developed. For example, the ... patient,s immune system are themselves targeted by the patient,s ... a team of researchers, led by Michael Morse, at ...
... By Amanda Gardner HealthDay Reporter , MONDAY, ... virus to fashion a therapeutic vaccine that appears to attack ... the required tumor-fighting immune response in early human trials, but ... expert urged caution. "They were able to generate an ...
... today announced that the United States (U.S.) Food and ... botulinum toxin type A for the treatment of adults ... study conducted in Rochester, Minnesota, the prevalence of focal ... at 295 per million people in the U.S. ...
Cached Medicine News:Health News:Iron oxide nanoparticles becoming tools for brain tumor imaging and treatment 2Health News:Heart Health Can Help Predict Brain Health: Study 2Health News:Heart Health Can Help Predict Brain Health: Study 3Health News:LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI 2Health News:LA Tumor Registry at LSUHSC awarded $12 million SEER contract by NCI 3Health News:Vaccine Shows Some Promise Against Advanced Cancers 2Health News:FDA approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm 2Health News:FDA approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm 3Health News:FDA approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm 4
Duckbill. 3.5 mm tip. Light curve....
2 mm. Angled 13 degrees, 15 mm from angle to tip. Round handle....
2 mm curved tip. Round handle. Designated most popular model or size....
Large. Double-ended. 3 mm pointed end and 5 mm angled end....
Medicine Products: